Impact of COVID-19 Pandemic on Intervals and Outcomes of Repeated Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma

Impact of COVID-19 Pandemic on Intervals and Outcomes of Repeated Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma

PurposeGiven that the novel coronavirus disease (COVID-19) pandemic has disrupted operations globally, an institution’s ability to repeat transarterial chemoembolization (TACE) for patients with hepatocellular carcinoma (HCC) has also been affected. The aim of this study was to evaluate the impact o...

Full description

Bibliographic Details
Main Authors: Zhi-Cheng Jin, Li Chen, Bin-Yan Zhong, Hai-Dong Zhu, Chu-Hui Zeng, Rui Li, Jin-He Guo, Shi-Cheng He, Gang Deng, Xiao-Li Zhu, Cai-Fang Ni, Gao-Jun Teng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
COVID-19
hepatocellular carcinoma
transarterial chemoembolization
follow-up interval
overall response rate
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.602700/full

Similar Items

Similar Items